Languages

French, English, and Arabic

Years of Experience

15

Professional Summary

Dr. Rami El Moukari is an expert Consultant Gastroenterologist with more than 15 years of experience in clinical gastroenterology and hepatology. Dr. Rami also has extensive experience in upper and lower GI endoscopy. In addition, Dr. Rami is a scientific speaker at local and international conferences as well as a reviewer for international journals. He obtained his MD certificate from Sant Joseph University, Beirut – Lebanon, and then got a diploma in medical training in gastroenterology and a master’s degree in Cell Biology from the University of Paris. Dr. Rami also got a PHD in 2010 in the field of liver diseases from the University of Paris. He has been working in Abu Dhabi since 2012.

Key procedures and Endoscopic surgeries

• Gastric Balloons for weight loss
• Endoscopic polypectomy
• Endoscopic Mucosa Resection (EMR)
• Percutaneous Endoscopic Gastrostomy (PEG)
• Endoscopic treatment of GI bleeding (clipping, coagulation, injection)
• Endoscopic varix therapy (Ligation, sclerotherapy, embolization)
• Dilatation of GI strictures (balloon dilatation)

• Abdominal Pain
• Gastroesophageal Reflux Disease
• H. Pylori Infection
• Chronic Constipation
• Irritable Bowel Syndrome
• Ulcerative Colitis
• Crohn’s Disease
• Celiac Disease
• Fatty Live

• Quantification of Hepatitis B Surface Antigen: A New Concept for the Management of Chronic Hepatitis BQuantification of Hepatitis B Surface Antigen: A New Concept for the Management of Chronic Hepatitis B
  LIVER INTERNATIONAL · Jan 1, 2011LIVER INTERNATIONAL · Jan 1, 2011
• Sequential therapy with Adefovir Dpivoxil and Pegylated Interferon Alfa-2a for HBeAg-negative PatientsSequential therapy with Adefovir Dpivoxil and Pegylated Interferon Alfa-2a for HBeAg-negative Patients
  JOURNAL OF VIRAL HEPATITIS · Jan 1, 2011JOURNAL OF VIRAL HEPATITIS · Jan 1, 2011
• Danoprevir, an HCV Protease Inhibitor Improves Insulin Sensitivity in Hepatitis C Genotype 1 PatientsDanoprevir, an HCV Protease Inhibitor Improves Insulin Sensitivity in Hepatitis C Genotype 1 Patients
  GUT · Jan 1, 2010GUT · Jan 1, 2010
• Impact of Peginterferon and Ribavirin Therapy on Hepatocellular Carcinoma: Incidence and Survival in Hepatitis C Patients with Advanced FibrosisImpact of Peginterferon and Ribavirin Therapy on Hepatocellular Carcinoma: Incidence and Survival in Hepatitis C Patients with Advanced Fibrosis
  JOURNAL OF HEPATOLOGY · Jan 1, 2010JOURNAL OF HEPATOLOGY · Jan 1, 2010
• Peginterferon for Chronic Hepatitis B: Predicting Success with On-Treatment BenchmarksPeginterferon for Chronic Hepatitis B: Predicting Success with On-Treatment Benchmarks
  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY · Jan 1, 2010
• The Neglected Hepatitis C Virus Genotypes 4, 5 and 6: An International Consensus ReportThe Neglected Hepatitis C Virus Genotypes 4, 5 and 6: An International Consensus Report
  LIVER INTERNATIONAL · Jan 1, 2010LIVER INTERNATIONAL · Jan 1, 2010
• Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative PatientsEarly Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
  HEPATOLOGY · Jan 1, 2009HEPATOLOGY · Jan 1, 2009
• High Rates of HBsAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Responding to Interferon: A Long-Term Follow-up StudyHigh Rates of HBsAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Responding to Interferon: A Long-Term Follow-up Study
  JOURNAL OF HEPATOLOGY · Jan 1, 2009JOURNAL OF HEPATOLOGY · Jan 1, 2009
• Insulin Resistance and Geographical Origin: Major Predictors of Liver Fibrosis and Response to Peginterferon and Ribavirin in HCV-4Insulin Resistance and Geographical Origin: Major Predictors of Liver Fibrosis and Response to Peginterferon and Ribavirin in HCV-4
  GUT · Jan 1, 2009GUT · Jan 1, 2009
• Levels and Initial Course of Serum Alanine Aminotransferase Can Predict Outcome of Patients With Budd-Chiari Syndrome
  CLINICAL GASTROENTEROLOGY AND HEPATOLOGY · Jan 1, 2009
• Prognostic Indices for Budd-Chiari Syndrome: Valid for Clinical Studies but Insufficient for Individual ManagementPrognostic Indices for Budd-Chiari Syndrome: Valid for Clinical Studies but Insufficient for Individual Management
  AMERICAN JOURNAL OF GASTROENTEROLOGY · Jan 1, 2009AMERICAN JOURNAL OF GASTROENTEROLOGY · Jan 1, 2009
• Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis CEradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
  GASTROENTEROLOGY · Jan 1, 2008GASTROENTEROLOGY · Jan 1, 2008
• Hepatocellular Carcinoma in Budd Chiari Syndrome: Characteristics and Risk FactorsHepatocellular Carcinoma in Budd Chiari Syndrome: Characteristics and Risk Factors
  GUT · Jan 1, 2008GUT · Jan 1, 2008
• Insulin Resistance in Chronic Hepatitis C: Association with Genotypes 1 and 4, Serum HCV RNA Level and Liver FibrosisInsulin Resistance in Chronic Hepatitis C: Association with Genotypes 1 and 4, Serum HCV RNA Level and Liver Fibrosis
  GASTROENTEROLOGY · Jan 1, 2008GASTROENTEROLOGY · Jan 1, 2008
• Acute Hepatitis E with Severe Jaundice: Report of Three CasesAcute Hepatitis E with Severe Jaundice: Report of Three Cases
  EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY · Jan 1, 2007EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY · Jan 1, 2007
• Amanita Phallaoides Poisoning: Reassessment of Prognostic Factors and Indications for Liver TransplantationAmanita Phallaoides Poisoning: Reassessment of Prognostic Factors and Indications for Liver Transplantation
  JOURNAL OF HEPATOLOGY · Jan 1, 2007JOURNAL OF HEPATOLOGY · Jan 1, 2007
• High Predictive Value of Early Viral Kinetics in Retreatment with Peginterferon and Ribavirin of Chronic Hepatitis C Patients Non-Responders to Standard Combination TherapyHigh Predictive Value of Early Viral Kinetics in Retreatment with Peginterferon and Ribavirin of Chronic Hepatitis C Patients Non-Responders to Standard Combination Therapy
  JOURNAL OF HEPATOLOGY · Jan 1, 2007JOURNAL OF HEPATOLOGY · Jan 1, 2007
• Non Alcoholic Steatohepatitis (NASH) in Hepatitis C: A Distinctive Entity More Common in Genotype 3 and not Associated with Metabolic DisordersNon Alcoholic Steatohepatitis (NASH) in Hepatitis C: A Distinctive Entity More Common in Genotype 3 and not Associated with Metabolic Disorders
  HEPATOLOGY · Jan 1, 2007HEPATOLOGY · Jan 1, 2007
• Hepatocellular Carcinoma in Lebanon: Etiology and Prognostic Factors Associated with Short-Term SurvivalHepatocellular Carcinoma in Lebanon: Etiology and Prognostic Factors Associated with Short-Term Survival
  WORLD JOURNAL OF GASTROENTEROLOGY · Jan 1, 2006